Entresto الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Aqumeldi الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

aqumeldi

proveca pharma limited - enalapril (maleate) - hjertefejl - agenter, der virker på renin-angiotensinsystemet - treatment of heart failure.